GLP-1 Medications and Immune Function: What Patients Should Know

Last reviewed: June 8, 2026

Last updated: June 8, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

GLP-1 medications activate receptors throughout the body, including immune cells, which can shift inflammatory patterns and metabolic signaling. Research shows that weight loss achieved through GLP-1 therapy often reduces systemic inflammation markers like C-reactive protein and IL-6. PlexusDx helps patients understand how their individual genetic profile may respond to these immune-metabolic changes.

How GLP-1 Receptors Influence Immune Cell Activity

GLP-1 receptors are not limited to the pancreas and gut—they appear on immune cells including T cells, macrophages, and dendritic cells. When medications like semaglutide bind these receptors, they can modulate how immune cells produce inflammatory signaling molecules called cytokines. This mechanism may explain why many patients on GLP-1 therapy report improved energy and reduced joint discomfort alongside weight loss.

Animal and early human studies indicate that GLP-1 activation can promote a shift toward anti-inflammatory immune responses. The vagus nerve, which connects the brain to organs including the immune system, plays a key role in this process. This gut-immune axis connection suggests that GLP-1 therapy works at multiple biological levels simultaneously.

GLP-1 Weight Loss and Reduction of Inflammatory Markers

Excess body fat, particularly visceral fat around organs, actively produces pro-inflammatory cytokines. As patients lose weight through semaglutide or tirzepatide therapy, fat tissue shrinks and releases fewer inflammatory molecules. Clinical trials consistently show drops in C-reactive protein, a marker of systemic inflammation, within weeks of starting GLP-1 treatment.

This anti-inflammatory benefit appears independent of weight loss alone—some immune improvements occur even before significant pounds are shed. Patients with baseline elevated inflammatory markers often experience the most dramatic improvements. PlexusDx uses the Precision Peptide Genetic Test to identify individual inflammatory pathway predispositions, helping customize therapy selection and monitoring expectations.

GLP-1 Medications and Autoimmune Response Considerations

Patients with existing autoimmune conditions often ask whether GLP-1 therapy might worsen their immune dysregulation. Current evidence suggests GLP-1 agonists generally support immune tolerance rather than triggering autoimmune flares, though individual responses vary. Anyone with conditions like type 1 diabetes, Hashimoto's thyroiditis, or rheumatoid arthritis should discuss GLP-1 use with their healthcare provider beforehand.

The Precision Peptide Genetic Test examines variants in other immune-related pathways to flag patients who may need closer immune monitoring. PlexusDx recommends baseline inflammatory markers (CRP, ESR) before starting compounded semaglutide injection at $189/mo (or $149/mo on the 6-month plan), with repeat testing at 8 weeks and 3 months to track changes.

GLP-1 Therapy and Infection Risk: What the Evidence Shows

A common concern is whether GLP-1 medications impair immune defenses against infections. Clinical trial data and real-world cohorts have not identified increased infection rates in patients taking semaglutide or tirzepatide. In fact, weight loss itself improves vaccine response and reduces severe infection risk in obese individuals.

Patients should maintain routine immunizations and standard infection prevention practices while on GLP-1 therapy. Anyone experiencing signs of infection—fever, persistent cough, unusual fatigue—should contact their doctor. PlexusDx provides ongoing clinical support to help patients recognize when immune changes warrant additional medical evaluation.

How Your Genetics Relate to GLP-1 Pathways

The PlexusDx Precision Peptide Genetic Test analyzes GIPR (rs1800437) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to GLP-1 medications or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Patients starting compounded semaglutide injection, oral semaglutide, or tirzepatide at PlexusDx can add the Precision Peptide Genetic Test for $298 after their first month of treatment. This test maps 14 immune and metabolic pathways across 49 peptides, delivering 150+ actionable genetic insights. Armed with personalized data, patients and their PlexusDx care team adjust therapy strategically rather than by trial and error.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Will GLP-1 medication like semaglutide weaken my immune system?

No—current evidence indicates GLP-1 agonists support immune function rather than suppress it. Weight loss achieved through compounded semaglutide injection ($189/month) typically reduces systemic inflammation and may improve immune tolerance. Discuss any specific immune concerns with your PlexusDx clinician before starting treatment.

Can GLP-1 therapy trigger or worsen autoimmune disease?

GLP-1 medications generally promote anti-inflammatory immune responses and have not been linked to autoimmune flares in clinical trials. Patients with existing autoimmune conditions can often use semaglutide or tirzepatide safely, but should inform their PlexusDx team beforehand. The Precision Peptide Genetic Test helps identify individual immune pathway predispositions.

How much does PlexusDx semaglutide cost, and is it covered by insurance?

Compounded semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan) through PlexusDx—a flat price that does not change with dose increases. PlexusDx serves all 50 states with no insurance requirement, membership fee, or prior authorization delays. HSA and FSA accounts are eligible for payment.

Will I have more infections while taking GLP-1 medication?

Clinical data show no increase in infection rates among patients on semaglutide or tirzepatide. Weight loss itself improves infection resistance and vaccine response. Continue routine preventive care, vaccinations, and hygiene; report any signs of infection to your healthcare team.

What is the Precision Peptide Genetic Test, and how does it help with immune function?

No — the Precision Peptide Genetic Test does not predict your response to GLP-1 medications or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Glp 1 Medications
• Do Genetic Tests Help Identify People Who Will Benefit From Glp 1 Medications
• Which Genes Affect Glp 1 Receptor Function
• Can A Dna Test Reveal If I Will Benefit From Glp 1 Medications

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.